Two methods of cell sychronization, density-dependent arrest and double thymidine block, were used to assign two Epstein-Barr virus-associated antigens to different parts of the growth cycle of the human B lymphblastoid cell lines, WI-L2 and Raji. The Epstein-Barr nuclear antigen (EBNA), as detected
Polymorphism of the ebna/rana antigen in epstein-barr virus—positive cell lines
✍ Scribed by Peter B. Billings; Sallie O. Hoch; John H. Vaughan
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 389 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Epstein–Barr virus (EBV) causes a range of life‐threatening B‐lymphocyte malignancies but, despite the use of various strategies, treatment remains problematic. ## Methods In the present study, we developed a non‐integrating lentiviral vector (NILV) that mediates specif
## Abstract B lymphocytes separated from anti‐HBe‐positive donors were established as lymphoblastoid cell lines by infection with EBV, but anti‐HBe in the culture supernatant from such lymphoblastoid cell lines could not be detected. The lymphoblastoid cell lines were rosetted with HBe antigen‐coup
## Abstract The Epstein‐Barr virus nuclear antigen I (EBNA I) is the only latent EBV antigen consistently expressed in malignant tissues of the nasopharynx. A 20‐amino‐acid synthetic peptide, p107 contains a major epitope of EBNA I. We tested sera from 210 patients with nasopharyngeal carcinoma (NP
## Abstract Epstein Barr virus (EBV) causes lymphomas in immune competent and, at increased frequencies, in immune compromised patients. In the presence of an intact immune system, EBV‐associated lymphomas express in most cases only 3 or fewer EBV antigens at the protein level, always including the